Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neoplasms × Algorithms × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 26 Cyclophosphamide 19 Nivolumab 15 Doxorubicin 12 Radiotherapy 9 Exercise 9 Carboplatin 9 atezolizumab 8 Surveys and Questionnaires 8 Rituximab 8 Prednisone 8 Paclitaxel 8 Docetaxel 8 Dexamethasone 8 Bevacizumab 8 venetoclax 7 fludarabine 7 budigalimab 7 Vincristine 7 Fluorouracil 7 Blood Specimen Collection 7 lenvatinib 6 dostarlimab 6 cemiplimab 6 Pemetrexed 6 Oxaliplatin 6 Cisplatin 6 Cetuximab 6 durvalumab 5 cabozantinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01806129 2025-06-13

EROS

Eastern Cooperative Oncology Group

Phase NA Active not recruiting

434 enrolled 9 charts

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡